Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ronco

Showing results (211-220 of 288) with videos related to

Pageof 29
Sort By:
Journal of the American Society of Nephrology : JASN|June 30, 2016
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-UpKarine Dahan, Hanna Debiec, Emmanuelle Plaisier, et al.
Pediatric Nephrology (Berlin, Germany)|March 24, 2025
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patientsMartina Riganati, Ester Conversano, Federica Zotta, et al.
Journal of the American Society of Nephrology : JASN|September 15, 2007
A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cellsAnne-Laure Sellier-Leclerc, Arnaud Duval, Stéphanie Riveron, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2008
Nephroangiosclerosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: is NOTCH3 mutation the common culprit?Dominique Guerrot, Arnaud François, Jean-Jacques Boffa, et al.
Kidney International|December 22, 2022
Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathyXiao-Dan Zhang, Cai-Xia Lin, Zhao Cui, et al.
Human Pathology|January 15, 2013
Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndromeAlyette Duquesne, Anabelle Werbrouck, Bettina Fabiani, et al.
Biomedicines|January 21, 2023
Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment TargetØystein Eikrem, Bjørnar Lillefosse, Nicolas Delaleu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2008
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA CouncilAdrian Covic, Jorge Cannata-Andia, Giovanni Cancarini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous NephropathyBarbara Seitz-Polski, Karine Dahan, Hanna Debiec, et al.
Talanta|January 22, 2017
Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomicsBenoît Gilquin, Mathilde Louwagie, Michel Jaquinod, et al.
Pageof 29

Showing results (211-220 of 288) with videos related to

Sort By:
Pageof 29
Journal of the American Society of Nephrology : JASN|June 30, 2016
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-UpKarine Dahan, Hanna Debiec, Emmanuelle Plaisier, et al.
Pediatric Nephrology (Berlin, Germany)|March 24, 2025
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patientsMartina Riganati, Ester Conversano, Federica Zotta, et al.
Journal of the American Society of Nephrology : JASN|September 15, 2007
A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cellsAnne-Laure Sellier-Leclerc, Arnaud Duval, Stéphanie Riveron, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2008
Nephroangiosclerosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: is NOTCH3 mutation the common culprit?Dominique Guerrot, Arnaud François, Jean-Jacques Boffa, et al.
Kidney International|December 22, 2022
Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathyXiao-Dan Zhang, Cai-Xia Lin, Zhao Cui, et al.
Human Pathology|January 15, 2013
Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndromeAlyette Duquesne, Anabelle Werbrouck, Bettina Fabiani, et al.
Biomedicines|January 21, 2023
Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment TargetØystein Eikrem, Bjørnar Lillefosse, Nicolas Delaleu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2008
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA CouncilAdrian Covic, Jorge Cannata-Andia, Giovanni Cancarini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous NephropathyBarbara Seitz-Polski, Karine Dahan, Hanna Debiec, et al.
Talanta|January 22, 2017
Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomicsBenoît Gilquin, Mathilde Louwagie, Michel Jaquinod, et al.
Pageof 29